Antipyretic, Analgesic & Nonsteroidal and Anti-inflammatory Compound Database (AAACD)
Project
name:Antipyretic, Analgesic & Nonsteroidal and Anti-inflammatory Compound Database (AAACD)
BuildTime:2023-04-21
Mark
At present, antipyretic, analgesic and non-steroidal anti-inflammatory drugs are one of the most used drugs in the world. Since aspirin was first synthesized in 1898, more than 100 brands have been on the market in more than 100 years, including aspirin, acetaminophen, indopexin, naproxen, ibuprofen and so on. It has antipyretic, analgesic, anti-inflammatory and anti-rheumatic effects.
Old drugs for new use mean that drugs that have been marketed are found to have new indications and are used to treat new diseases. There are many successful examples of new use: Gleevec, for leukemia can be used to treat malignant gastrointestinal stromal tumors; aspirin, as an anti-inflammatory drug, can be used to prevent cardiovascular disease and colorectal cancer; and many older drugs have also played an important role in COVID-19.
This database received in the stages of drug development of different antipyretic analgesia and non-steroidal anti-inflammatory drugs, anti-inflammatory analgesic and non-steroidal anti-inflammatory drugs, anti-tumor action mechanism of the systematic statistics, provides the current market antipyretic analgesic anti-inflammatory drugs anti-tumor activity and clinical trial progress information. Therefore, this database can be used as an auxiliary tool to help the new use of old drugs, monitor the dynamics of drug development, and conduct the pharmacodynamic screening of the anti-tumor effects of antipyretic and analgesic anti-inflammatory drugs.